Karel MckeeKarel Mckee
|
 |
Effects of three combined oral contraceptives contraceptive preparations containing desogestrel plus ethinyl contraception names for antidepressants estradiol on lipid metabolism in aping with two levonorgestrel preparations.The effects of three different desogestrel-containing combined oral contraceptive preparations on lipid metabolism contraceptives were compared with those of two levonorgestrel preparations. Advances in IUD technology include Cu-safe 300 (a slim device best pharmacy no prescription with an anti-expulsion design), the flexigard (a frameless device associated with reduced pain and bleeding), and Levonorgestrel-releasing devices. Recent innovations in the field of barrier methods include the female condom and cervical cap; plastic is being tested as a component of male condoms. seasonale Low-density lipoprotein cholesterol levels were increased in monophasic levonorgestrel and clearly decreased in the lowest ethinyl estradiol-containing monophasic desogestrel (150/20) and biphasic desogestrel preparations. (1) monophasic desogestrel (150/30), (2) monophasic desogestrel (150/20, containing 20 micrograms of ethinyl estradiol instead of 30 micrograms seasonale drug of ethinyl estradiol, (3) biphasic desogestrel, (4) monophasic levonorgestrel (150/30), and (5) triphasic levonorgestrel. For postpartum contraception, researchers are working on a delivery system for natural progesterone, and lactational yasmin amenorrhea has gained recognition as an effective method of pregnancy prevention.. The differences seen between the desogestrel and levonorgestrel preparations can best be explained by the lower intrinsic androgenicity of 3-keto-desogestrel (active metabolite of desogestrel) than that of levonorgestrel. As protection against tender immunodeficiency virus (HIV) transmission jolessa becomes a central concern among safety shoes users, the condom has increased in popularity. Bioself 110, an electronic fertility indicator, refines the practice of round family planning. The monophasic desogestrel (150/30) and biphasic desogestrel preparations induced higher high-density lipoprotein cholesterol and apolipoprotein A-I levels than did their levonorgestrel-containing counterparts. New thinking in contraception.contraceptive research and development is currently addressing the preservation of female fertility through birth control, the promotion of birth control as an essential component of a healthy life-style, and prevention of the spread of sexually transmitted diseases. The effects of these preparations were assessed on high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A-I, apolipoprotein B, the ratio of high-density lipoprotein cholesterol to low-density lipoprotein cholesterol, and the ratio of apolipoprotein A-I to apolipoprotein B after 3 months of treatment, and the percentage changes with regard to pretreatment were calculated. The combined oral contraceptive (OC) remains the most popular birth control method, and the introduction of new progestogens has lowered the incidence of cycle control problems and improved metabolic data. Apolipoprotein B increased in all preparations. The antiatherogenic indexes (ratios of high-density lipoprotein cholesterol to low-density lipoprotein cholesterol and apolipoprotein A-I to apolipoprotein B were higher for monophasic desogestrel (150/30) and biphasic desogestrel than for comparable levonorgestrel-containing preparations. The following preparations were studied. Among new bag delivery systems are the vaginal ring, Norplant, and momently combined injectables.
|